• $131.00
    Market Cap
  • -100.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
645,810
+176.60%
233,485
+11.04%
210,279
+6.67%
197,136
N/A
Cost of Revenue
188,108
+246.30%
54,319
N/A
N/A
N/A
N/A
N/A
Gross Profit
457,702
+155.46%
179,166
-14.80%
210,279
+6.67%
197,136
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-2.2M
-45.29%
-4.0M
+136.57%
-1.7M
N/A
N/A
N/A
Depreciation and Amortization Expense
841,217
-0.03%
841,444
+1,818.00%
43,871
+2,126.95%
1,970
N/A
Total Operating Expenses
34.5M
-7.89%
37.5M
+315.24%
9.0M
+50.61%
6.0M
N/A
Operating Profit
-34.1M
-8.67%
-37.3M
+323.11%
-8.8M
+52.10%
-5.8M
N/A
Interest Income
N/A
N/A
3,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-45,450
N/A
Interest Income and Expense and Net
0
-100.00%
3,000
N/A
0
+100.00%
-45,450
N/A
Total Nonoperating Income and Expense
-35.5M
+4,110.18%
-842,074
-61.31%
-2.2M
+4,688.88%
-45,450
N/A
Income before Taxes
-34.1M
-8.67%
-37.3M
+323.11%
-8.8M
+52.10%
-5.8M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Net Income
-69.5M
+82.20%
-38.2M
+247.03%
-11.0M
+88.16%
-5.8M
N/A
Net Income from Continuing Operations Applicable to Common
-69.5M
+82.20%
-38.2M
+247.03%
-11.0M
+88.16%
-5.8M
N/A
Basic EPS and Net Income
-1.53
+62.77%
-0.94
+203.23%
-0.31
+40.91%
-0.22
N/A
Diluted EPS and Net Income
-1.53
+62.77%
-0.94
+203.23%
-0.31
+40.91%
-0.22
N/A
Basic Weighted Average Shares
45.5M
+11.65%
40.7M
+13.00%
36.0M
+36.66%
26.4M
N/A
Diluted Weighted Average Shares
45.5M
+11.65%
40.7M
+13.00%
36.0M
+36.66%
26.4M
N/A
Balance Sheet
Cash and Cash Equivalents
148,465
-70.94%
510,865
-87.46%
4.1M
+40.29%
2.9M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
148,465
-70.94%
510,865
-87.46%
4.1M
+40.29%
2.9M
N/A
Total Current Assets
968,778
-50.45%
2.0M
-55.58%
4.4M
+41.72%
3.1M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
1,970
N/A
Property and Plant and Equipment and Net
12,500
-0.36%
12,545
-2.12%
12,817
+79.96%
7,122
N/A
Total Long-Term Assets
21.0M
-42.70%
36.7M
-40.37%
61.6M
+864,790.93%
7,122
N/A
Total Assets
22.0M
-43.10%
38.7M
-41.38%
66.0M
+40.17%
47.1M
N/A
Income Taxes Payable
N/A
N/A
697
-91.52%
8,215
N/A
N/A
N/A
Total Short-Term Debt
17.0M
+1,397.33%
1.1M
-10.12%
1.3M
N/A
N/A
N/A
Total Current Liabilities
22.6M
+674.97%
2.9M
-6.76%
3.1M
+334.40%
721,395
N/A
Total Long-Term Debt
25.8M
+48.17%
17.4M
+3,608.61%
469,252
N/A
N/A
N/A
Total Long-Term Liabilities
6.1M
-66.89%
18.3M
+20.88%
15.2M
+1,312.26%
1.1M
N/A
Total Liabilities
28.7M
+35.03%
21.3M
+16.15%
18.3M
+919.47%
1.8M
N/A
Retained Earnings
-155.5M
+80.87%
-86.0M
+79.81%
-47.8M
+29.86%
-36.8M
N/A
Total Stockholders Equity
-6.7M
-138.46%
17.4M
-63.47%
47.7M
+5.31%
45.3M
N/A
Total Shares Outstanding
131.8M
+225.19%
40.5M
+0.000007%
40.5M
+12.80%
35.9M
N/A
Cash Flow
Cash from Operating Activities
-4.7M
-56.83%
-10.9M
+87.52%
-5.8M
+79.51%
-3.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
148,656
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
-148,656
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.3M
-40.71%
7.3M
+4.80%
7.0M
+10.86%
6.3M
N/A
Financials Ratio
Gross Margin
70.87%
-7.64%
76.74%
N/A
N/A
N/A
N/A
N/A
Operating Margin
-5,278.10%
-66.98%
-15,985.52%
+281.05%
-4,195.09%
+42.60%
-2,941.93%
N/A
Return on Assets
-229.11%
+214.22%
-72.91%
+274.86%
-19.45%
+25.95%
-15.44%
N/A
Return on Equity
-1,297.23%
+1,006.56%
-117.23%
+395.54%
-23.66%
+49.01%
-15.88%
N/A
Revenue Growth
176.60%
+1,500.21%
11.04%
+65.53%
6.67%
N/A
N/A
N/A
Current Ratio
0.04
-93.60%
0.67
-52.36%
1.40
-67.38%
4.31
N/A
Cash Ratio
0.007
-96.22%
0.17
-86.55%
1.30
-67.70%
4.02
N/A
Debt-to-Equity Ratio
-6.38
-699.64%
1.06
+2,830.85%
0.04
N/A
N/A
N/A
Debt-to-Assets Ratio
1.94
+305.30%
0.48
+1,728.63%
0.03
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow